A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.

Hamre, Harald J; Pham, Van N; Kern, Christian; Rau, Rolf; Klasen, Jörn; Schendel, Ute; Gerlach, Lars; Drabik, Attyla; Simon, Ludger

Hamre, Harald J; Pham, Van N; Kern, Christian; Rau, Rolf; Klasen, Jörn; Schendel, Ute; Gerlach, Lars; Drabik, Attyla; Simon, Ludger.

Afiliación

Hamre HJ; Institute for Applied Epistemology and Medical Methodology at the Witten/Herdecke University, Freiburg, Germany.
Pham VN; Institute of Statistics in Medicine, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Kern C; Department of Integrative Medicine, Asklepios Westklinikum, Hamburg, Germany.
Rau R; Department of Rheumatology, Evangelisches Fachkrankenhaus Ratingen, Ratingen, Germany.
Klasen J; Department of Integrative Medicine, Asklepios Westklinikum, Hamburg, Germany.
Schendel U; Department of Rheumatology, m&i-Fachklinik Bad Pyrmont, Bad Pyrmont, Germany.
Gerlach L; Department of Internal Medicine and Gastroenterology, Filderklinik, Filderstadt, Germany.
Drabik A; Institute of Statistics in Medicine, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Simon L; Department of Internal Medicine and Gastroenterology, Filderklinik, Filderstadt, Germany.

Patient Prefer Adherence ; 12: 375-397, 2018.

Article en En | MEDLINE | ID: mdl-29588576

Palabras clave

Phase IV; clinical trial; disease-modifying antirheumatic drugs; integrative medicine; patient preference; rheumatoid arthritis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Complementárias: Medicina_antroposofica Tipo de estudio: Clinical_trials Idioma: En Revista: Patient Prefer Adherence Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google